• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage publications (all current information on this profile has been aggregated automatically from publisher and metadata sources).
  • Mika Miura, Shinya Maekawa, +8 authors Nobuyuki Enomoto
  • Medicine, Biology
  • Hepatology research : the official journal of the…
  • 2014 (First Publication: 1 December 2014)
  • AIM Daclatasvir, a non-structural (NS)5A replication complex inhibitor, is a potent and promising direct antiviral agent (DAA) for hepatitis C virus (HCV), being most effective in genotype 1bContinue Reading
  • Makoto Kadokura, Shinya Maekawa, +11 authors Nobuyuki Enomoto
  • Biology, Medicine
  • PloS one
  • 2011 (First Publication: 15 September 2011)
  • BACKGROUND AND AIMS Patients infected with genotype 2b hepatitis C virus (HCV) generally can achieve favorable responses to pegylated-interferon plus ribavirin therapy (PEG-IFN/RBV). However, aContinue Reading
  • Mika Miura, Shinya Maekawa, +11 authors Nobuyuki Enomoto
  • Biology, Medicine
  • Journal of virology
  • 2013 (First Publication: 1 December 2013)
  • Variation of core amino acid (aa) 70 of hepatitis C virus (HCV) has been shown recently to be closely correlated with liver disease progression, suggesting that the core region might be present as aContinue Reading
  • Shinichi Takano, Mitsuharu Fukasawa, +6 authors Nobuyuki Enomoto
  • Biology, Medicine
  • PloS one
  • 2014 (First Publication: 4 June 2014)
  • BACKGROUND To clarify the genetic mutations associated with intraductal papillary mucinous neoplasms (IPMN) and IPMN-related pancreatic tumours, we conducted cancer-related gene profiling analysesContinue Reading
  • Makoto Kadokura, Shinya Maekawa, +11 authors Nobuyuki Enomoto
  • Medicine
  • Hepatology international
  • 2011 (First Publication: 1 September 2011)
  • PurposeA proportion of patients infected with genotype 2a hepatitis C virus (HCV) cannot achieve a sustained virological response (SVR) to pegylated-interferon plus ribavirin therapy (PEG-IFN/RBV)Continue Reading
  • Nobutoshi Komatsu, Utaroh Motosugi, +18 authors Nobuyuki Enomoto
  • Medicine
  • Hepatology research : the official journal of the…
  • 2014 (First Publication: 1 December 2014)
  • AIM To investigate whether the patients with hypovascular liver nodules determined on the arterial phase and hypointensity on the hepatocyte phase gadoxetic acid-enhanced magnetic resonance imagingContinue Reading
  • Shinya Maekawa, Minoru Sakamoto, +16 authors Nobuyuki Enomoto
  • Medicine, Biology
  • Hepatology
  • 2012 (First Publication: 1 November 2012)
  • UNLABELLED To comprehensively characterize the contribution of virological factors as well as interleukin-28B (IL28B) single-nucleotide polymorphisms (SNPs) in determining treatment responses inContinue Reading